Publications by authors named "T Vicente"
Polycystic liver disease (PLD) is a hereditary condition, and its symptoms are due to the growth of cysts. Liver transplantation (LT) is the only curative treatment. A retrospective single-center analysis was conducted on the 10 LTs performed for PLD between 2004 and 2023.
View Article and Find Full Text PDFIntroduction: The hypothermic oxygenated perfusion (HOPE) system has been developed to improve the quality of previously considered suboptimal liver grafts, reduce complications, and increase the number of available donors. The aim of this study is to evaluate the results since its implementation in the liver transplant (LT) program at our center.
Materials And Methods: We conducted a retrospective descriptive analysis of all LTs with HOPE from August 2022 to November 2023 with a minimum follow-up of 3 months.
Background/objectives: Magnetic nanoparticles (MNPs) have gained attention in theranostics for their ability to combine diagnostic imaging and therapeutic capabilities in a single platform, enhancing targeted treatment and monitoring. Surface coatings are essential for stabilizing MNPs, improving biocompatibility, and preventing oxidation that could compromise their functionality. Natural rubber latex (NRL) offers a promising coating alternative due to its biocompatibility and stability-enhancing properties.
View Article and Find Full Text PDFArticle Synopsis
- Klebsiella michiganensis is an emerging hospital pathogen that often carries antibiotic-resistance genes, including those for carbapenemases, prompting a redefined outbreak alert in a Spanish pediatric ward.
- The study analyzed 31 isolates of K. oxytoca with a focus on VIM-carbapenemase, using whole-genome sequencing to establish genetic relationships and identify resistance genes.
- The results confirmed an outbreak involving 18 cases across three wards, revealing complex interconnections and potential hidden reservoirs for the infection, underscoring the importance of genomic analysis in outbreak management.
Article Synopsis
- The study assesses how effective short courses of treatment are for patients with carbapenemase-producing Enterobacterales bloodstream infections (CPE-BSI) between 2014 and 2022.
- It includes 105 patient episodes, dividing them into two groups: those receiving treatment for 3-10 days (short treatment group) and those treated for over 10 days (long treatment group).
- Results indicate no significant differences in outcomes between the two groups, suggesting that short treatment durations can be effective if the treatment is appropriate and source control is achieved.